Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides

Montserrat Goles,Anamaría Daza,Gabriel Cabas-Mora,Lindybeth Sarmiento-Varón,Julieta Sepúlveda-Yañez,Hoda Anvari-Kazemabad,Mehdi D Davari,Roberto Uribe-Paredes,Álvaro Olivera-Nappa,Marcelo A Navarrete,David Medina-Ortiz
DOI: https://doi.org/10.1093/bib/bbae275
IF: 9.5
2024-06-12
Briefings in Bioinformatics
Abstract:With their diverse biological activities, peptides are promising candidates for therapeutic applications, showing antimicrobial, antitumour and hormonal signalling capabilities. Despite their advantages, therapeutic peptides face challenges such as short half-life, limited oral bioavailability and susceptibility to plasma degradation. The rise of computational tools and artificial intelligence (AI) in peptide research has spurred the development of advanced methodologies and databases that are pivotal in the exploration of these complex macromolecules. This perspective delves into integrating AI in peptide development, encompassing classifier methods, predictive systems and the avant-garde design facilitated by deep-generative models like generative adversarial networks and variational autoencoders. There are still challenges, such as the need for processing optimization and careful validation of predictive models. This work outlines traditional strategies for machine learning model construction and training techniques and proposes a comprehensive AI-assisted peptide design and validation pipeline. The evolving landscape of peptide design using AI is emphasized, showcasing the practicality of these methods in expediting the development and discovery of novel peptides within the context of peptide-based drug discovery.
biochemical research methods,mathematical & computational biology
What problem does this paper attempt to address?
### Problems Addressed by the Paper This paper aims to explore how artificial intelligence (AI) technology can accelerate the design and discovery of peptide-based drugs. Specifically, the paper focuses on the following aspects: 1. **Advantages and Challenges of Peptide Drugs**: - Peptide drugs possess various biological activities, such as antibacterial, antitumor, and hormone signaling capabilities. - Despite the high selectivity, strong affinity, good efficacy, and high safety of peptide drugs, their short half-life, low oral bioavailability, and susceptibility to plasma degradation limit their widespread clinical application. 2. **Application of Computational Tools and AI Methods**: - With the increase in peptide sequences and their functional data, numerous computational tools have been developed to store and share peptide information. - Machine learning (ML) and artificial intelligence (AI) methods have been widely applied in peptide research, particularly in protein engineering. 3. **AI-Assisted Peptide Design Methods**: - Classification Methods: Used to identify different biological activities of peptides, from biological functions to classification attributes. - Predictive Models: Used to estimate peptide binding affinity, assess toxicity, and predict inhibitory activity. - Deep Generative Models (DGMs): Especially Generative Adversarial Networks (GANs), Variational Autoencoders (VAEs), and diffusion models, which can generate new peptide sequences with specific targets. 4. **Challenges in Peptide Design**: - Automated or assisted peptide design still faces several challenges, such as peptide handling optimization, establishing information representation strategies, and the careful development and validation of predictive models. 5. **AI-Assisted Peptide Design and Validation Process**: - A comprehensive AI-assisted peptide design and validation process is proposed, and the different challenges faced in achieving autonomous peptide drug design are discussed. In summary, this paper mainly explores how to use artificial intelligence technology to overcome various challenges in peptide drug design and proposes a series of AI-based peptide design methods.